-
Something wrong with this record ?
Biomarkers of fibroproliferative healing in fibrosing idiopathic interstitial pneumonias
M. Vasakova, M. Sterclova, E. Stranska, P. Mandakova, J. Skibova, R. Matej,
Language English Country Netherlands
Grant support
NT13433
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Bentham Science Publishers OA
from 2007-07-30
Free Medical Journals
from 2007
PubMed Central
from 2007
Europe PubMed Central
from 2007 to 2018
Open Access Digital Library
from 2007-01-01
Open Access Digital Library
from 2007-01-01
Open Access Digital Library
from 2007-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2007
- Keywords
- IL4R.; Idiopathic interstitial pneumonias; PAR-2; TGF-beta; biomarkers; bronchoalveolar lavage fluid; fibroproliferative healing,
- MeSH
- Biomarkers * MeSH
- Bronchoalveolar Lavage Fluid * MeSH
- Idiopathic Pulmonary Fibrosis * MeSH
- Idiopathic Interstitial Pneumonias * MeSH
- Humans MeSH
- Receptor, PAR-2 * MeSH
- Receptors, Interleukin-4 * MeSH
- Transforming Growth Factor beta * MeSH
- Check Tag
- Humans MeSH
AIMS: The main feature of fibrosing idiopathic interstitial pneumonias (fIIPs) is the fibroproliferative potential of underlying pathogenetic process. We hypothesize that the concentration of potential markers of fibroproliferative healing, PAR-2, TGF-β1, TNF-α and IL-4Rα in bronchoalveolar lavage fluid (BALF) differ in patients with fIIPs compared to controls (C). PATIENTS AND METHODS: 10 patients with fIIPs and 9 controls (C) were included to the study. Concentrations of CD124 (IL4Rα), PAR-2, TGF-β1 and TNF-α in BALF were determined using the ELISA method. RESULTS: We observed higher concentrations of IL4Rα (fIIPS 1499.4 pg/ml vs C 255.5 pg/ml; p < 0.05), PAR-2 (fIIPS 1807.9 pg/ml vs C 421.0 pg/ml; p < 0.05) and TGF-β1(fIIPS 283.0 pg/ml vs C 197.1 pg/ml; p < 0.01) in BALF in fIIPs versus C. The values of TNF-a in BALF did not differ significantly in fIIPs compared to controls. The ratios also showed differences in fIIPS and C: IL4Rα/TGF-β1 (fIIPS 6.19 vs C 0.68; p = 0.0143); TNF-α/IL4Rα (fIIPS 0.84 vs C 7.93; p = 0.043); TGF-β1/TNF-α (fIIPS 0.21 vs C 0.16; p = 0.0179) and protein/PAR-2 (fIIPS 0.06 vs C 0.28; p = 0.0033). CONCLUSIONS: We found that PAR-2, TGF-β1 and IL-4Rα are significantly up-regulated in the BALF of fIIPs compared to controls, therefore we suppose they could become biomarkers of fibroproliferative healing.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13016264
- 003
- CZ-PrNML
- 005
- 20170524123450.0
- 007
- ta
- 008
- 130424s2012 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2174/1874306401206010160 $2 doi
- 035 __
- $a (PubMed)23346263
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Koziar Vašáková, Martina, $u Department of Respiratory Medicine, Thomayer Hospital, Videnska 800, 14059 Prague 4, Czech Republic. $d 1964- $7 xx0104496
- 245 10
- $a Biomarkers of fibroproliferative healing in fibrosing idiopathic interstitial pneumonias / $c M. Vasakova, M. Sterclova, E. Stranska, P. Mandakova, J. Skibova, R. Matej,
- 520 9_
- $a AIMS: The main feature of fibrosing idiopathic interstitial pneumonias (fIIPs) is the fibroproliferative potential of underlying pathogenetic process. We hypothesize that the concentration of potential markers of fibroproliferative healing, PAR-2, TGF-β1, TNF-α and IL-4Rα in bronchoalveolar lavage fluid (BALF) differ in patients with fIIPs compared to controls (C). PATIENTS AND METHODS: 10 patients with fIIPs and 9 controls (C) were included to the study. Concentrations of CD124 (IL4Rα), PAR-2, TGF-β1 and TNF-α in BALF were determined using the ELISA method. RESULTS: We observed higher concentrations of IL4Rα (fIIPS 1499.4 pg/ml vs C 255.5 pg/ml; p < 0.05), PAR-2 (fIIPS 1807.9 pg/ml vs C 421.0 pg/ml; p < 0.05) and TGF-β1(fIIPS 283.0 pg/ml vs C 197.1 pg/ml; p < 0.01) in BALF in fIIPs versus C. The values of TNF-a in BALF did not differ significantly in fIIPs compared to controls. The ratios also showed differences in fIIPS and C: IL4Rα/TGF-β1 (fIIPS 6.19 vs C 0.68; p = 0.0143); TNF-α/IL4Rα (fIIPS 0.84 vs C 7.93; p = 0.043); TGF-β1/TNF-α (fIIPS 0.21 vs C 0.16; p = 0.0179) and protein/PAR-2 (fIIPS 0.06 vs C 0.28; p = 0.0033). CONCLUSIONS: We found that PAR-2, TGF-β1 and IL-4Rα are significantly up-regulated in the BALF of fIIPs compared to controls, therefore we suppose they could become biomarkers of fibroproliferative healing.
- 650 12
- $a idiopatické intersticiální pneumonie $7 D054988
- 650 12
- $a receptor PAR-2 $7 D044464
- 650 12
- $a receptory interleukinu-4 $7 D019948
- 650 12
- $a transformující růstový faktor beta $7 D016212
- 650 12
- $a bronchoalveolární lavážní tekutina $7 D001992
- 650 12
- $a biologické markery $7 D015415
- 650 12
- $a idiopatická plicní fibróza $7 D054990
- 650 _2
- $a lidé $7 D006801
- 653 00
- $a IL4R.; Idiopathic interstitial pneumonias; PAR-2; TGF-beta; biomarkers; bronchoalveolar lavage fluid; fibroproliferative healing
- 700 1_
- $a Šterclová, Martina, $d 1979- $7 xx0108032
- 700 1_
- $a Stránská, Eliška $7 xx0143239
- 700 1_
- $a Manďáková, Petra $7 xx0121856
- 700 1_
- $a Skibová, Jelena $7 xx0061183
- 700 1_
- $a Matěj, Radoslav, $d 1974- $7 xx0103860
- 773 0_
- $w MED00165360 $t The open respiratory medicine journal $x 1874-3064 $g Roč. 6(2012), s. 160-164
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23346263 $y Pubmed
- 910 __
- $a ABA008 $b sig $y 4 $z 0
- 990 __
- $a 20130424 $b ABA008
- 991 __
- $a 20170524123847 $b ABA008
- 999 __
- $a ok $b bmc $g 979465 $s 814585
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 6 $d 160-164 $i 1874-3064 $m The open respiratory medicine journal $n Open Respir Med J $x MED00165360
- GRA __
- $a NT13433 $p MZ0
- LZP __
- $a Pubmed-20130424